{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T15:19:39Z","timestamp":1790263179529,"version":"4.1.0"},"reference-count":186,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrinology and Metabolism Clinics of North America"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.ecl.2013.07.007","type":"journal-article","created":{"date-parts":[[2013,9,26]],"date-time":"2013-09-26T03:07:05Z","timestamp":1380164825000},"page":"915-946","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Diabetes and the Female Reproductive System"],"prefix":"10.1016","volume":"42","author":[{"given":"Anindita","family":"Nandi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonid","family":"Poretsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ecl.2013.07.007_bib1","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1001\/jama.1925.02670060022007","article-title":"The growth, development, and prognosis of diabetic children","volume":"85","author":"Joslin","year":"1985","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.ecl.2013.07.007_bib2","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1210\/edrv-8-2-132","article-title":"The gonadotropic function of insulin","volume":"8","author":"Poretsky","year":"1987","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ecl.2013.07.007_bib3","volume":"Tomus primus","year":"1765"},{"key":"10.1016\/j.ecl.2013.07.007_bib4","first-page":"51","article-title":"Le virilisme et son association a l\u2019insuffisnace glycolytique (diabete des femme a barbe)","volume":"86","author":"Achard","year":"1921","journal-title":"Acad Natl Med"},{"issue":"14","key":"10.1016\/j.ecl.2013.07.007_bib5","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1056\/NEJM197604012941401","article-title":"The syndromes of insulin resistance and acanthosis nigricans: insulin receptor disoreders in man","volume":"294","author":"Kahn","year":"1976","journal-title":"N\u00a0Engl J Med"},{"issue":"4209","key":"10.1016\/j.ecl.2013.07.007_bib6","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1126\/science.170678","article-title":"Antibodies that impair insulin receptor binding in an unusual diabetic syndrome with severe insulin resistance","volume":"190","author":"Flier","year":"1975","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.ecl.2013.07.007_bib7","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1210\/er.2011-1034","article-title":"Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications","volume":"33","author":"Diamanti-Kandarakis","year":"2012","journal-title":"Endocr Rev"},{"issue":"3","key":"10.1016\/j.ecl.2013.07.007_bib8","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1748-1716.2010.02201.x","article-title":"Tissue specificity on insulin action and resistance: past to recent mechanisms","volume":"201","author":"Benito","year":"2011","journal-title":"Acta Physiol (Oxf)"},{"issue":"4","key":"10.1016\/j.ecl.2013.07.007_bib9","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1210\/edrv.20.4.0374","article-title":"The insulin-related ovarian regulatory system in health and disease","volume":"20","author":"Poretsky","year":"1999","journal-title":"Endocr Rev"},{"issue":"4","key":"10.1016\/j.ecl.2013.07.007_bib10","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1210\/jcem-59-4-809","article-title":"Specific insulin binding sites in human ovary","volume":"59","author":"Poretsly","year":"1984","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.ecl.2013.07.007_bib11","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1210\/jcem-61-4-728","article-title":"Distribution and characterization of insulin and insulin-like growth factor I receptors in normal human ovary","volume":"61","author":"Poretsky","year":"1985","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.ecl.2013.07.007_bib12","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1210\/jcem-67-4-774","article-title":"Regulation of insulin receptors in the human ovary: in\u00a0vitro studies","volume":"67","author":"Poretsky","year":"1988","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.ecl.2013.07.007_bib13","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0026-0495(90)90070-S","article-title":"Regulation of human ovarian insulin receptors in\u00a0vivo","volume":"39","author":"Poretsky","year":"1990","journal-title":"Metabolism"},{"issue":"2","key":"10.1016\/j.ecl.2013.07.007_bib14","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1152\/physrev.00032.2003","article-title":"Mouse models of insulin resistance","volume":"84","author":"Nandi","year":"2004","journal-title":"Physiol Rev"},{"issue":"2","key":"10.1016\/j.ecl.2013.07.007_bib15","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1210\/endo-122-2-581","article-title":"The effects of experimental hyperinsulinemia on steroid secretion, ovarian (125I) insulin binding, and ovarian (125I) insulin-like growth factor I binding in the rat","volume":"122","author":"Poretsky","year":"1988","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.ecl.2013.07.007_bib16","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0015-0282(16)47243-2","article-title":"Effects of insulin on steroidogenesis in cultured porcine ovarian theca","volume":"40","author":"Barbieri","year":"1983","journal-title":"Fertil Steril"},{"issue":"12","key":"10.1016\/j.ecl.2013.07.007_bib17","doi-asserted-by":"crossref","first-page":"3788","DOI":"10.1210\/jcem.80.12.8530637","article-title":"Insulin action in human granulosa cells from normal and polycystic ovaries is mediated by the insulin receptor and not the type-1 insulin-like growth factor receptor","volume":"80","author":"Willis","year":"1995","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.ecl.2013.07.007_bib18","first-page":"2001","article-title":"Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and usng inositolglycan mediators as the signal transduction system","volume":"83","author":"Nestler","year":"1998","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.ecl.2013.07.007_bib19","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/0002-9378(84)90769-5","article-title":"Aromatase activity in human granulosa cells during follicular development and the modulation by follicle-stimulating hormone and insulin","volume":"148","author":"Garzo","year":"1984","journal-title":"Am J Obstet Gynecol"},{"issue":"9","key":"10.1016\/j.ecl.2013.07.007_bib20","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1056\/NEJM199608293350902","article-title":"Decreases in ovarian cytochrome P450c17a activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome","volume":"335","author":"Nestler","year":"1996","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.ecl.2013.07.007_bib21","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/1071-5576(94)00061-5","article-title":"The effects of insulin on 3 beta-hydroxysteroid dehydrogenase expression in human luteinized granulosa cells","volume":"2","author":"McGee","year":"1995","journal-title":"J\u00a0Soc Gynecol Investig"},{"issue":"6","key":"10.1016\/j.ecl.2013.07.007_bib22","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1210\/jcem-71-6-1653","article-title":"Androgen response to endogenous insulin secretion during the frequently sampled intravenous glucose tolerance test in normal and hyperandrogenic women","volume":"71","author":"Falcone","year":"1990","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.ecl.2013.07.007_bib23","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1365-2265.1992.tb00958.x","article-title":"Lack of linear relationship between hyperinsulinemia and hyperandrogenism","volume":"36","author":"Toscano","year":"1992","journal-title":"Clin Endocrinol"},{"issue":"3","key":"10.1016\/j.ecl.2013.07.007_bib24","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1365-2265.1991.tb03531.x","article-title":"Correlation of plasma insulin and insulin-like growth factor-1 with indices of androgen transport and metabolism in women with polycystic ovary syndrome","volume":"35","author":"Sharp","year":"1991","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.ecl.2013.07.007_bib25","series-title":"Polycystic ovary syndrome","first-page":"279","article-title":"Acute augmentation of plasma androstenedione and dehydroepiandrosterone by euglycemic insulin infusion: evidence for a direct effect of insulin on ovarian steroidogenesis","author":"Stuart","year":"1992"},{"issue":"6","key":"10.1016\/j.ecl.2013.07.007_bib26","first-page":"921","article-title":"Hyperinsulinemia and hyperandrogenism: in\u00a0vivo androgen response to insulin infusion","volume":"69","author":"Stuart","year":"1987","journal-title":"Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.ecl.2013.07.007_bib27","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/S0015-0282(16)53931-4","article-title":"Insulin infusion acutely augments ovarian androgen production in normal women","volume":"54","author":"Stuart","year":"1990","journal-title":"Fertil Steril"},{"issue":"6","key":"10.1016\/j.ecl.2013.07.007_bib28","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/0022-4731(88)90344-5","article-title":"Androgen levels during sequential insulin euglycemic clamp studies in patients with polycystic ovary disease","volume":"31","author":"Micic","year":"1988","journal-title":"J\u00a0Steroid Biochem"},{"issue":"1","key":"10.1016\/j.ecl.2013.07.007_bib29","first-page":"302","article-title":"Modulation by insulin of follicle-stimulating hormone and luteinizing hormone actions in human granulosa cells of normal and polycystic ovaries","volume":"81","author":"Willis","year":"1996","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.ecl.2013.07.007_bib30","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1210\/endo-123-2-733","article-title":"Insulin-like growth factor I and insulin potentiate luteinizing hormone-induced androgen synthesis","volume":"123","author":"Cara","year":"1988","journal-title":"Endocrinology"},{"issue":"2\u20133","key":"10.1016\/j.ecl.2013.07.007_bib31","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0303-7207(84)90005-4","article-title":"Insulin enhances FSH-stimulated steroidogenesis by cultured rat granulosa cells","volume":"35","author":"Davoren","year":"1984","journal-title":"Mol Cell Endocrinol"},{"issue":"3","key":"10.1016\/j.ecl.2013.07.007_bib32","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3109\/09513599409072455","article-title":"The role of insulin in ovarian size in patients with polycystic ovary syndrome","volume":"8","author":"Markussis","year":"1994","journal-title":"Gynecol Endocrinol"},{"issue":"5","key":"10.1016\/j.ecl.2013.07.007_bib33","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/0026-0495(94)90209-7","article-title":"Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy","volume":"43","author":"Velazquez","year":"1994","journal-title":"Metabolism"},{"issue":"9","key":"10.1016\/j.ecl.2013.07.007_bib34","first-page":"3299","article-title":"The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome","volume":"81","author":"Dunaif","year":"1996","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ecl.2013.07.007_bib35","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0300-595X(84)80006-7","article-title":"Biological and immunological properties of insulin-like growth factors (IGF) I and II","volume":"13","author":"Zapf","year":"1984","journal-title":"Clin Endocrinol Metab"},{"issue":"1\u20132","key":"10.1016\/j.ecl.2013.07.007_bib36","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/dmr.5610010103","article-title":"Insulin receptors and the molecular mechanism of insulin action","volume":"1","author":"Kahn","year":"1985","journal-title":"Diabetes Metab Rev"},{"issue":"5","key":"10.1016\/j.ecl.2013.07.007_bib37","first-page":"1411","article-title":"Expression of insulin-like growth factor-1 ( IGF-1) and IGF-II and the IGF-I, IGF-II, and insulin receptor genes and localization of the gene products in the human ovary","volume":"77","author":"El-Roeiy","year":"1993","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.ecl.2013.07.007_bib38","first-page":"1003","article-title":"Expression of insulin-like growth factor (IGF), IGF binding protein, and IGF receptor messenger ribonucleic acids in normal and polycystic ovaries","volume":"81","author":"Voutilainen","year":"1996","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.ecl.2013.07.007_bib39","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1210\/edrv-15-3-369","article-title":"Growth hormone (GH) insensitivity due to primary GH receptor deficiency","volume":"15","author":"Rosenfeld","year":"1994","journal-title":"Endocr Rev"},{"issue":"9","key":"10.1016\/j.ecl.2013.07.007_bib40","first-page":"3412","article-title":"Insulin-like growth factor II (IGF-II) inhibits insulin-like growth factor binding protein I (IGFBP-1) production in luteinized human granulosa cells with a potency similar to insulin-like growth factor I (IGF-I)","volume":"81","author":"Poretsky","year":"1996","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.ecl.2013.07.007_bib41","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0889-8529(05)70342-X","article-title":"The role of the insulin-like growth factor binding proteins and the IGFBP proteases in modulating IGF action","volume":"25","author":"Collett-Solberg","year":"1996","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"6","key":"10.1016\/j.ecl.2013.07.007_bib42","first-page":"1488","article-title":"Expression of the genes encoding the insulin-like growth factors (IGF-I and II), the IGF and insulin receptors, and IGF-binding proteins 1-6 and the localization of their gene products in normal and polycystic ovary syndrome ovaries","volume":"78","author":"El-Roeiy","year":"1994","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.ecl.2013.07.007_bib43","first-page":"493","article-title":"Insulin receptor mediates inhibitory effect of insulin, but not of insulin-like growth factor (IGF-I), on IGF binding protein (IGFBP-1) production on human granulosa cells","volume":"81","author":"Poretsky","year":"1996","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.ecl.2013.07.007_bib44","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/BF02212589","article-title":"Regulation of IGF binding proteins by FSH in human luteinizing granulosa cells","volume":"12","author":"Adachi","year":"1995","journal-title":"J\u00a0Assist Reprod Genet"},{"issue":"3","key":"10.1016\/j.ecl.2013.07.007_bib45","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S0015-0282(97)00248-3","article-title":"Regulation of insulin-like growth factor-binding protein-1and progesterone secretion by cultured human granulosa-luteal cells: effects of octreotide and insulin","volume":"68","author":"Holst","year":"1997","journal-title":"Fertil Steril"},{"issue":"3","key":"10.1016\/j.ecl.2013.07.007_bib46","first-page":"625","article-title":"Insulin-like growth factor-binding proteins in healthy and atretic follicles during natural menstrual cycles","volume":"76","author":"San Roman","year":"1993","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.ecl.2013.07.007_bib47","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1210\/jcem.74.4.1372322","article-title":"Insulin-like growth factor binding protein profiles in human ovarian follicular fluid correlate with follicular functional status","volume":"74","author":"Cataldo","year":"1992","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.ecl.2013.07.007_bib48","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1210\/jcem-71-5-1330","article-title":"Identification of insulin-like growth factor-binding protein-3 (IGFBP-3) and IGFBP-2 in human follicular fluid","volume":"71","author":"Giudice","year":"1990","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ecl.2013.07.007_bib49","first-page":"91","article-title":"Proteolysis of IGFBP-3 may be a common regulatory mechanism of IGF action in\u00a0vivo","volume":"3","author":"Lamson","year":"1993","journal-title":"Growth Regul"},{"issue":"6734","key":"10.1016\/j.ecl.2013.07.007_bib50","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/20694","article-title":"Signals from the reproductive system regulate the lifespan of C. Elegans","volume":"399","author":"Hsin","year":"1999","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.ecl.2013.07.007_bib51","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0092-8674(00)80799-0","article-title":"Autonomous control of cell and organ size by CHICO, a Drosophila homolog of vertebrate IRS 1-4","volume":"97","author":"Bohni","year":"1999","journal-title":"Cell"},{"issue":"Pt 4","key":"10.1016\/j.ecl.2013.07.007_bib52","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1042\/bst0290525","article-title":"Insulin receptor substrate proteins and neuroendocrine function","volume":"29","author":"Withers","year":"2001","journal-title":"Biochem Soc Trans"},{"issue":"5487","key":"10.1016\/j.ecl.2013.07.007_bib53","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1126\/science.289.5487.2122","article-title":"Role of brain insulin receptor in control of body weight and reproduction","volume":"289","author":"Bruning","year":"2000","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.ecl.2013.07.007_bib54","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1172\/JCI200421645","article-title":"Transgenic rescue of insulin receptor-deficient mice","volume":"114","author":"Okamoto","year":"2004","journal-title":"J\u00a0Clin Invest"},{"issue":"3","key":"10.1016\/j.ecl.2013.07.007_bib55","doi-asserted-by":"crossref","first-page":"346","DOI":"10.2337\/diacare.21.3.346","article-title":"The relationship of menstrual irregularity to type 2 diabetes in Pima Indian Women","volume":"21","author":"Roumain","year":"1998","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.ecl.2013.07.007_bib56","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1210\/en.2009-0788","article-title":"The effect of insulin signaling on female reproductive function independent of adiposity and hyperglycemia","volume":"151","author":"Nandi","year":"2010","journal-title":"Endocrinology"},{"issue":"19","key":"10.1016\/j.ecl.2013.07.007_bib57","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1001\/jama.286.19.2421","article-title":"Long or highly irregular menstrual cycles as a marker for risk of type 2 diabetes mellitus","volume":"286","author":"Solomon","year":"2001","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.ecl.2013.07.007_bib58","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1016\/j.fertnstert.2010.03.044","article-title":"Menstrual cycle characteristics and risk of coronary heart disease and type 2 diabetes","volume":"94","author":"Gast","year":"2010","journal-title":"Fertil Steril"},{"issue":"10","key":"10.1016\/j.ecl.2013.07.007_bib59","doi-asserted-by":"crossref","first-page":"e26076","DOI":"10.1371\/journal.pone.0026076","article-title":"Age at menarche and its association with the metabolic syndrome and its components: results from the KORA F4 Study","volume":"6","author":"Stockl","year":"2011","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.ecl.2013.07.007_bib60","doi-asserted-by":"crossref","first-page":"E1007","DOI":"10.1210\/jc.2010-2526","article-title":"Age at menarche and metabolic markers for type 2 diabetes in premenopausal women: the Biocycle Study","volume":"96","author":"Chen","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.ecl.2013.07.007_bib61","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s00125-011-2410-3","article-title":"Age at menarche is associated with prediabetes and diabetes in women (age 32-81) from the general population: the KORA F4 Study","volume":"55","author":"Stockl","year":"2012","journal-title":"Diabetologia"},{"issue":"5","key":"10.1016\/j.ecl.2013.07.007_bib62","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/j.1464-5491.2011.03489.x","article-title":"The role of BMI across the life course in the relationship between age at menarche and diabetes in a British Birth Cohort","volume":"29","author":"Pierce","year":"2012","journal-title":"Diabet Med"},{"issue":"1","key":"10.1016\/j.ecl.2013.07.007_bib63","first-page":"73","article-title":"Polycystic ovary syndrome in adolescents","volume":"13","author":"Kent","year":"2002","journal-title":"Adolesc Med"},{"key":"10.1016\/j.ecl.2013.07.007_bib64","first-page":"1","article-title":"The gonadal function in female diabetics","volume":"19","author":"Bergqvist","year":"1954","journal-title":"Acta Endocrinol Suppl (Copenh)"},{"issue":"8","key":"10.1016\/j.ecl.2013.07.007_bib65","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/0002-9378(82)90466-5","article-title":"Clinical and hormonal characteristics in women with anovulation and insulin-treated diabetes mellitus","volume":"143","author":"Djursing","year":"1982","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ecl.2013.07.007_bib66","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1477-7827-9-61","article-title":"Menarche delay and menstrual irregularities persist in adolescents with type 1 diabetes","volume":"9","author":"Schweiger","year":"2011","journal-title":"Reprod Biol Endocrinol"},{"issue":"5","key":"10.1016\/j.ecl.2013.07.007_bib67","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1016\/j.fertnstert.2007.09.035","article-title":"Menarche in type 1 diabetes is still delayed despite good metabolic control","volume":"90","author":"Picardi","year":"2008","journal-title":"Fertil Steril"},{"issue":"5","key":"10.1016\/j.ecl.2013.07.007_bib68","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1016\/j.fertnstert.2009.08.039","article-title":"Menstrual cycle irregularities and their relationship with HbA1c and insulin dose in adolescents with type 1 diabetes mellitus","volume":"94","author":"Gaete","year":"2010","journal-title":"Fertil Steril"},{"issue":"1","key":"10.1016\/j.ecl.2013.07.007_bib69","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.fertnstert.2010.10.041","article-title":"Ovulation rate in adolescents with type 1 diabetes mellitus","volume":"95","author":"Codner","year":"2011","journal-title":"Fertil Steril"},{"issue":"8","key":"10.1016\/j.ecl.2013.07.007_bib70","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.2337\/diabetes.50.8.1857","article-title":"Menopause in type 1 diabetic women: is it premature?","volume":"50","author":"Dorman","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.ecl.2013.07.007_bib71","first-page":"12","article-title":"Puberty and ovarian function in girls with type 1 diabetes mellitus","volume":"71","author":"Codner","year":"2009","journal-title":"Horm Res"},{"issue":"6","key":"10.1016\/j.ecl.2013.07.007_bib72","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1210\/jc.2006-0108","article-title":"Diagnostic criteria for polycystic ovary syndrome and ovarian morphology in women with type 1 diabetes mellitus","volume":"91","author":"Codner","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.ecl.2013.07.007_bib73","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1210\/jc.2006-2641","article-title":"Clinical review: hyperandrogenism and polycystic ovary syndrome in women with type 1 diabetes mellitus","volume":"92","author":"Codner","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.ecl.2013.07.007_bib74","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1210\/jcem.83.9.5143","article-title":"Syndromes of severe insulin resistance","volume":"83","author":"Tritos","year":"1998","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2013.07.007_bib75","series-title":"Principles of diabetes mellitus","first-page":"259","article-title":"Syndromes of extreme insulin resistance","author":"Grunberger","year":"2010"},{"issue":"1","key":"10.1016\/j.ecl.2013.07.007_bib76","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1210\/edrv-12-1-3","article-title":"On the paradox of insulin-induced hyperandrogenism in insulin-resistant states","volume":"12","author":"Poretsky","year":"1991","journal-title":"Endocr Rev"},{"issue":"6","key":"10.1016\/j.ecl.2013.07.007_bib77","doi-asserted-by":"crossref","first-page":"851","DOI":"10.7326\/0003-4819-97-6-851","article-title":"Insulin resistance associated with androgen excess in women with auto-antibodies to the insulin receptor","volume":"97","author":"Taylor","year":"1982","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.ecl.2013.07.007_bib78","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0015-0282(16)60060-2","article-title":"The role of hyperinsulinemia in the pathogenesis of ovarian hyperandrogenism","volume":"50","author":"Barbieri","year":"1988","journal-title":"Fertil Steril"},{"issue":"3","key":"10.1016\/j.ecl.2013.07.007_bib79","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1210\/jcem-38-3-347","article-title":"Remission of acanthosis nigricans associated with polycystic ovarian disease and a stromal luteoma","volume":"38","author":"Givens","year":"1973","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.ecl.2013.07.007_bib80","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0015-0282(16)47716-2","article-title":"The influence of androgens on insulin resistance","volume":"41","author":"Shoupe","year":"1984","journal-title":"Fertil Steril"},{"issue":"4","key":"10.1016\/j.ecl.2013.07.007_bib81","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1056\/NEJM198607243150402","article-title":"Impaired insulin action in puberty","volume":"315","author":"Amiel","year":"1986","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.ecl.2013.07.007_bib82","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1210\/jcem-68-5-971","article-title":"The administration of pharmacological doses of testosterone or 19-nortestosterone to normal men is not associated with increased insulin secretion or impaired glucose tolerance","volume":"68","author":"Friedl","year":"1989","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.ecl.2013.07.007_bib83","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/S0002-9378(87)80319-8","article-title":"Effect of chronically elevated androgen or estrogen on the glucose tolerance test and insulin response in female rhesus monkeys","volume":"157","author":"Billiar","year":"1987","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.ecl.2013.07.007_bib84","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1530\/eje.0.1360475","article-title":"Short and long-term metabolic effects of recombinant human IGF-1 treatment in patients with severe insulin resistance and diabetes mellitus","volume":"136","author":"Vestergaard","year":"1997","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ecl.2013.07.007_bib85","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0002-9378(15)30642-6","article-title":"Amenorrhea associated with bilateral polycystic ovaries","volume":"29","author":"Stein","year":"1935","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.ecl.2013.07.007_bib86","doi-asserted-by":"crossref","first-page":"299.e1","DOI":"10.1016\/j.ajog.2012.07.023","article-title":"Prevalence of polycystic ovary syndrome among the privately insured, United States, 2003-2008","volume":"207","author":"Okoron","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ecl.2013.07.007_bib87","series-title":"Principals of diabetes mellitus","first-page":"515","article-title":"Polycystic ovary syndrome","author":"Zweig","year":"2010"},{"issue":"5","key":"10.1016\/j.ecl.2013.07.007_bib88","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1016\/j.fertnstert.2010.09.032","article-title":"Polycystic ovary syndrome: an ancient disorder","volume":"95","author":"Azziz","year":"2011","journal-title":"Fertil Steril"},{"issue":"12","key":"10.1016\/j.ecl.2013.07.007_bib89","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1056\/NEJMra041536","article-title":"Polycystic ovary syndrome","volume":"352","author":"Ehrmann","year":"2005","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.ecl.2013.07.007_bib90","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.metabol.2003.10.005","article-title":"Pathogenesis of polycystic ovary syndrome: what is the role of obesity?","volume":"53","author":"Salehi","year":"2004","journal-title":"Metabolism"},{"issue":"9","key":"10.1016\/j.ecl.2013.07.007_bib91","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.2337\/diab.38.9.1165","article-title":"Profound peripheral insulin resistance; independent of obesity, in polycystic ovary syndrome","volume":"38","author":"Dunaif","year":"1989","journal-title":"Diabetes"},{"issue":"10","key":"10.1016\/j.ecl.2013.07.007_bib92","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1161\/01.CIR.103.10.1410","article-title":"Polycystic ovary syndrome is associated with endothelial dysfunction","volume":"103","author":"Paradisi","year":"2001","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.ecl.2013.07.007_bib93","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1210\/jc.2002-020386","article-title":"Troglitazone therapy improves endothelaial function to near normal levels in women with polcystic ovary syndrome","volume":"88","author":"Paradisi","year":"2003","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.ecl.2013.07.007_bib94","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1093\/humupd\/7.6.522","article-title":"Polycystic ovary syndrome and cancer","volume":"7","author":"Balen","year":"2001","journal-title":"Hum Reprod Update"},{"issue":"7","key":"10.1016\/j.ecl.2013.07.007_bib95","first-page":"2248","article-title":"Determinants of abnormal gonadotropin secretion in clinically defined women with polycystic ovary syndrome","volume":"82","author":"Taylor","year":"1997","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.ecl.2013.07.007_bib96","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.steroids.2011.12.007","article-title":"Neuroendocrine dysfunction in polycystic ovary syndrome","volume":"77","author":"Solorzano","year":"2012","journal-title":"Steroids"},{"issue":"8","key":"10.1016\/j.ecl.2013.07.007_bib97","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/0026-0495(92)90175-A","article-title":"Hyperinsulunemia and human chorionic gonadotropin synergistically promote the growth of ovarian follicular cysts in rats","volume":"41","author":"Poretsky","year":"1992","journal-title":"Metabolism"},{"issue":"1","key":"10.1016\/j.ecl.2013.07.007_bib98","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.mce.2010.08.002","article-title":"The role of low grade inflammation in the polycystic ovary syndrome","volume":"335","author":"Repaci","year":"2011","journal-title":"Mol Cell Endocrinol"},{"issue":"1","key":"10.1016\/j.ecl.2013.07.007_bib99","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1172\/JCI29881","article-title":"Obesity induces a phenotype switch in adipose tissue macrophage polarization","volume":"117","author":"Lumeng","year":"2007","journal-title":"J\u00a0Clin Invest"},{"issue":"1","key":"10.1016\/j.ecl.2013.07.007_bib100","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1530\/EJE-07-0133","article-title":"Metformin administration improves leukocyte count in women with polycystic ovary syndrome: a 6-month prospective study","volume":"157","author":"Orio","year":"2007","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"10.1016\/j.ecl.2013.07.007_bib101","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1210\/endo-126-5-2711","article-title":"Effects of TNF\u03b1 in\u00a0vitro on steroidogenesis in healthy and atretic follicles of the rat theca as a target","volume":"126","author":"Roby","year":"1990","journal-title":"Endocrinology"},{"issue":"4","key":"10.1016\/j.ecl.2013.07.007_bib102","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1095\/biolreprod61.4.993","article-title":"TNF\u03b1 stimulates proliferation of rat ovarian theca-interstitial cells","volume":"61","author":"Spaczynski","year":"1999","journal-title":"Biol Reprod"},{"issue":"7","key":"10.1016\/j.ecl.2013.07.007_bib103","first-page":"2343","article-title":"IL-6 and the IL-6 receptor in the human adrenal gland: expression and effects on steroidogenesis","volume":"82","author":"Path","year":"1997","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ecl.2013.07.007_bib104","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1210\/jc.2006-1665","article-title":"Differential gene expression profile in omental adipose tissue in women with PCOS","volume":"92","author":"Croton","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ecl.2013.07.007_bib105","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1210\/endo-128-1-379","article-title":"Testosterone increases lipolysis and the number of beta-adrenoreceptors in male rat adipocytes","volume":"128","author":"Xu","year":"1991","journal-title":"Endocrinology"},{"issue":"4","key":"10.1016\/j.ecl.2013.07.007_bib106","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1210\/endo-108-4-1441","article-title":"Insulin enhancement of luteinizing hormone and follicle-stimulating hormone release by cultured pituitary cells","volume":"108","author":"Adashi","year":"1981","journal-title":"Endocrinology"},{"issue":"6","key":"10.1016\/j.ecl.2013.07.007_bib107","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1530\/eje.0.1310641","article-title":"Insulin, insulin-like growth factor I (IGF-I) and IGF-II enhance basal and gonadotropin-releasing hormone-stimulated luteinizing hormone release from rat anterior pituitary cells in\u00a0vitro","volume":"131","author":"Soldani","year":"1994","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"10.1016\/j.ecl.2013.07.007_bib108","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1507\/endocrj.40.413","article-title":"Altered expression of insulin and insulin-like growth factor-1 receptors in follicular and stromal compartments of polycystic ovaries","volume":"40","author":"Samoto","year":"1993","journal-title":"Endocr J"},{"issue":"6 pt 1","key":"10.1016\/j.ecl.2013.07.007_bib109","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1016\/0002-9378(90)90786-7","article-title":"Specific binding sites for insulin-like growth factor-1 in the ovarian stroma of women with polycystic ovarian disease and stromal hyperthecosis","volume":"163","author":"Nagamani","year":"1990","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.ecl.2013.07.007_bib110","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2147\/IJWH.S11304","article-title":"Treatment options for polycystic ovary syndrome","volume":"201","author":"Badawy","year":"2011","journal-title":"Int J Womens Health"},{"issue":"5","key":"10.1016\/j.ecl.2013.07.007_bib111","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.contraception.2006.12.019","article-title":"The safety of a drospirenone-containing oral contraceptive: final results from the European Active Surveillance Study on oral contraceptives based on 142,475 women-years of observation","volume":"75","author":"Dinger","year":"2007","journal-title":"Contraception"},{"issue":"3","key":"10.1016\/j.ecl.2013.07.007_bib112","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1097\/01.AOG.0000279448.62221.a8","article-title":"Risk of thromboembolism in women taking ethinyl estradiol\/drospirenone and other oral contraceptives","volume":"110","author":"Seejer","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ecl.2013.07.007_bib113","doi-asserted-by":"crossref","first-page":"d2139","DOI":"10.1136\/bmj.d2139","article-title":"Risk of venous thromboembolism in users of oral contraceptives containing drospirenone or levonorgestrel: nested case-control study based on UK General Practice Research Database","volume":"342","author":"Parkin","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.ecl.2013.07.007_bib114","doi-asserted-by":"crossref","first-page":"d2151","DOI":"10.1136\/bmj.d2151","article-title":"Risk of non-fatal venous thromboembolism in women using oral contraceptives containing drospirenone compared with women using oral contraceptives containing levonogestrel: case-control study using United States claims data","volume":"342","author":"Jick","year":"2011","journal-title":"BMJ"},{"issue":"10","key":"10.1016\/j.ecl.2013.07.007_bib115","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1111\/j.1464-5491.2010.03098.x","article-title":"Metformin action on AMP-activated protein kinase: a translational research approach to understanding a potential therapeutic target","volume":"27","author":"Boyle","year":"2010","journal-title":"Diabet Med"},{"issue":"3","key":"10.1016\/j.ecl.2013.07.007_bib116","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3132\/dvdr.2008.027","article-title":"Metformin therapy and clinical uses","volume":"5","author":"Scarpello","year":"2008","journal-title":"Diab Vasc Dis Res"},{"issue":"1","key":"10.1016\/j.ecl.2013.07.007_bib117","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ecl.2005.09.005","article-title":"Fertility in polycystic ovary syndrome","volume":"35","author":"Patel","year":"2006","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"4","key":"10.1016\/j.ecl.2013.07.007_bib118","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.ecl.2011.08.003","article-title":"Achieving a successful pregnancy in women with polycystic ovary syndrome","volume":"40","author":"Araki","year":"2011","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"12","key":"10.1016\/j.ecl.2013.07.007_bib119","doi-asserted-by":"crossref","first-page":"6364","DOI":"10.1210\/jc.2005-1490","article-title":"The polycystic ovary syndrome associated with morbid obesity may resolve after weight loss induced by bariatric surgery","volume":"90","author":"Escobar-Morreale","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.ecl.2013.07.007_bib120","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.tem.2003.08.002","article-title":"Polycystic ovary syndrome: syndrome XX?","volume":"14","author":"Sam","year":"2003","journal-title":"Trends Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.ecl.2013.07.007_bib121","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1097\/GCO.0b013e32833e1264","article-title":"Insulin-sensitizing agents in the treatment of polycystic ovary syndrome: an update","volume":"22","author":"Katsiki","year":"2010","journal-title":"Curr Opin Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.ecl.2013.07.007_bib122","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1038\/sj.bjp.0707452","article-title":"Thiazolidinediones: effects on insulin resistance and the cardiovascular system","volume":"153","author":"Quinn","year":"2008","journal-title":"Br J Pharmacol"},{"issue":"4","key":"10.1016\/j.ecl.2013.07.007_bib123","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1055\/s-0030-1270525","article-title":"Rosiglitazone and pioglitazone inhibit estrogen synthesis in human granulosa cells by interfering with androgen binding to aromatase","volume":"43","author":"Seto-Young","year":"2011","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.ecl.2013.07.007_bib124","doi-asserted-by":"crossref","first-page":"926438","DOI":"10.1155\/2011\/926438","article-title":"Rosiglitazone and pioglitazone alter aromatase kinetic porperties in human granulosa cells","volume":"2011","author":"Araki","year":"2011","journal-title":"PPAR Res"},{"issue":"24","key":"10.1016\/j.ecl.2013.07.007_bib125","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1056\/NEJMoa072761","article-title":"Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes","volume":"356","author":"Nissen","year":"2007","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"10.1016\/j.ecl.2013.07.007_bib126","doi-asserted-by":"crossref","first-page":"E675","DOI":"10.1503\/cmaj.112102","article-title":"Use of thiazolidinediones and the risk of bladder cancer among people with type 2 diabetes: a meta-analysis","volume":"184","author":"Colmers","year":"2012","journal-title":"CMAJ"},{"issue":"5","key":"10.1016\/j.ecl.2013.07.007_bib127","doi-asserted-by":"crossref","first-page":"845","DOI":"10.2337\/dc07-2270","article-title":"Rosiglitazone-associated fractures in type 2 diabetes: an analysis from A Diabetes Outcome Progression Trial (ADOPT)","volume":"31","author":"Kahn","year":"2008","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.ecl.2013.07.007_bib128","first-page":"1","article-title":"Thiazolidinediones (TZDs) affect osteoblast viability and biomarkers independently of the TZD effects on aromatase","volume":"45","author":"Seth","year":"2013","journal-title":"Horm Metab Res"},{"issue":"7","key":"10.1016\/j.ecl.2013.07.007_bib129","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1210\/jc.2008-0115","article-title":"Comparison of single and combined treatment with exenatide and metformin on menstrual cyclicity in overweight women with polycystic ovary syndrome","volume":"93","author":"Elkind-Hirsch","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.ecl.2013.07.007_bib130","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1093\/humrep\/17.7.1729","article-title":"Clinical, endocrine and metabolic effects of metformin added to ethinyl estradiol-cyproterone acetate in non-obese women with polycystic ovary syndrome: a randomized controlled study","volume":"17","author":"Elter","year":"2002","journal-title":"Hum Reprod"},{"issue":"1","key":"10.1016\/j.ecl.2013.07.007_bib131","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/humrep\/dei312","article-title":"Rosiglitazone and ethinyl estradiol\/cyproterone acetate as single and combined treatment of overweight women with polycystic ovary syndrome and insulin resistance","volume":"21","author":"Lemay","year":"2006","journal-title":"Hum Reprod"},{"issue":"6","key":"10.1016\/j.ecl.2013.07.007_bib132","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/MED.0b013e328359ff92","article-title":"Reproductive impact of polycystic ovary syndrome","volume":"19","author":"Usaadi","year":"2012","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"6","key":"10.1016\/j.ecl.2013.07.007_bib133","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1056\/NEJMoa063971","article-title":"Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome","volume":"356","author":"Legro","year":"2007","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.ecl.2013.07.007_bib134","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1080\/01443610903147576","article-title":"Metformin in the treatment of clomiphene citrate-resistant women with polycystic ovary syndrome undergoing in\u00a0vitro fertilization treatment: a randomized controlled trial","volume":"29","author":"Qublan","year":"2009","journal-title":"J\u00a0Obstet Gynaecol"},{"issue":"2","key":"10.1016\/j.ecl.2013.07.007_bib135","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1080\/00016340802638199","article-title":"Pregnancy outcome after ovulation induction with aromatase inhibitors or clomiphene citrate in unexplained infertility","volume":"88","author":"Badawy","year":"2009","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"4","key":"10.1016\/j.ecl.2013.07.007_bib136","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s00404-012-2672-0","article-title":"Clomiphene combined with gonadotropins and GnRH antagonist versus conventional controlled ovarian hyperstimulation without clomiphene in women undergoing assisted reproductive techniques: systematic review and meta-analysis","volume":"287","author":"Figuerido","year":"2013","journal-title":"Arch Gynecol Obstet"},{"issue":"3","key":"10.1016\/j.ecl.2013.07.007_bib137","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.fertnstert.2007.08.034","article-title":"Clomiphene citrate or anastrozole for ovulation induction in women with polycystic ovary syndrome? A prospective randomized trial","volume":"92","author":"Badawy","year":"2009","journal-title":"Fertil Steril"},{"issue":"3","key":"10.1016\/j.ecl.2013.07.007_bib138","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.cct.2011.12.005","article-title":"The Pregnancy in Polycystic Ovary Syndrome II(PPCOS II) Trial: rationale and design of a double-blind randomized trial of clomiphene citrate and letrozole for the treatment of infertility in women with polycystic ovary syndrome","volume":"33","author":"Legro","year":"2012","journal-title":"Contemp Clin Trials"},{"issue":"1","key":"10.1016\/j.ecl.2013.07.007_bib139","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/humupd\/dmi036","article-title":"A\u00a0meta-analysis of outcomes of conventional IVF in women with polycystic ovary syndrome","volume":"12","author":"Heijnem","year":"2006","journal-title":"Hum Reprod Update"},{"issue":"8","key":"10.1016\/j.ecl.2013.07.007_bib140","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s10815-007-9127-8","article-title":"Application of GnRH antagonist in combination with clomiphene citrate and hMG for patients with exaggerated ovarian response in previous IVF\/ICSI cycles","volume":"24","author":"Lin","year":"2007","journal-title":"J\u00a0Assist Reprod Genet"},{"issue":"5","key":"10.1016\/j.ecl.2013.07.007_bib141","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/S0015-0282(02)04206-1","article-title":"Use of dexamethasone and clomiphene citrate in the treatment of clomiphene citrate-resistant patients with polycystic ovary syndrome and normal dehydroepiandrostene sulfate levels: a prospective, double-blind, placebo-controlled trial","volume":"78","author":"Parasanezhad","year":"2002","journal-title":"Fertil Steril"},{"issue":"1","key":"10.1016\/j.ecl.2013.07.007_bib142","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1055\/s-2007-992927","article-title":"Pregnancy complications in women with polycystic ovary syndrome","volume":"26","author":"Boomsma","year":"2008","journal-title":"Semin Reprod Med"},{"issue":"3","key":"10.1016\/j.ecl.2013.07.007_bib143","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00404-010-1495-0","article-title":"Polycystic ovarian syndrome and pregnancy outcome","volume":"282","author":"Iavazzo","year":"2010","journal-title":"Arch Gynecol Obstet"},{"issue":"1","key":"10.1016\/j.ecl.2013.07.007_bib144","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/OGX.0b013e31815e85fc","article-title":"Polycystic ovary syndrome and oocyte developmental competence","volume":"63","author":"Dumesic","year":"2007","journal-title":"Obstet Gynecol Surv"},{"issue":"1","key":"10.1016\/j.ecl.2013.07.007_bib145","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1055\/s-2007-992925","article-title":"Implications of polycystic ovary syndrome on oocyte development","volume":"26","author":"Dumesic","year":"2008","journal-title":"Semin Reprod Med"},{"issue":"2","key":"10.1016\/j.ecl.2013.07.007_bib146","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1210\/jcem.87.2.8207","article-title":"Effects of metformin on early pregnancy loss in the polycystic ovary syndrome","volume":"87","author":"Jakubowicz","year":"2002","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.ecl.2013.07.007_bib147","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1093\/humrep\/17.11.2858","article-title":"Pregnancy outcomes among women with polycystic ovary syndrome treated with metformin","volume":"17","author":"Glueck","year":"2002","journal-title":"Hum Reprod"},{"issue":"3","key":"10.1016\/j.ecl.2013.07.007_bib148","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/S0015-0282(01)03202-2","article-title":"Metformin therapy throughout pregnancy reduces the development of gestational diabetes in women with polycystic ovary syndrome","volume":"77","author":"Glueck","year":"2002","journal-title":"Fertil Steril"},{"issue":"1","key":"10.1016\/j.ecl.2013.07.007_bib149","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0015-0282(00)01666-6","article-title":"Continuing metformin throughout pregnancy in women with polycystic ovary syndrome appears to safely reduce first trimester spontaneous abortion: a pilot study","volume":"75","author":"Glueck","year":"2001","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ecl.2013.07.007_bib150","series-title":"Principles of diabetes mellitus","first-page":"233","article-title":"Diabetes in pregnancy","author":"Schneider","year":"2010"},{"issue":"6","key":"10.1016\/j.ecl.2013.07.007_bib151","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1097\/AOG.0b013e31823974e2","article-title":"Gestational diabetes mellitus","volume":"118","author":"Landon","year":"2008","journal-title":"Obstet Gynecol"},{"issue":"Suppl 1","key":"10.1016\/j.ecl.2013.07.007_bib152","first-page":"S4","article-title":"Report on the expert committee on the diagnosis and classification if diabetes mellitus","volume":"23","author":"Expert Committee on the Diagnosis and Classification of Diabetes Mellitus","year":"2000","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.ecl.2013.07.007_bib153","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.mito.2010.03.002","article-title":"Maternal diabetes and oocyte quality","volume":"10","author":"Wang","year":"2010","journal-title":"Mitochondrion"},{"issue":"1","key":"10.1016\/j.ecl.2013.07.007_bib154","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1758-5996-4-41","article-title":"Adverse pregnancy outcomes in women with diabetes","volume":"4","author":"Negrato","year":"2012","journal-title":"Diabetol Metab Syndr"},{"issue":"19","key":"10.1016\/j.ecl.2013.07.007_bib155","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1056\/NEJMoa0707943","article-title":"HAPO Study Cooperative Research Group: hyperglycemia and adverse pregnancy outcomes","volume":"358","author":"Metzger","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"2 pt 1","key":"10.1016\/j.ecl.2013.07.007_bib156","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/AOG.0b013e318203ebe0","article-title":"The relationship between maternal glycemia and perinatal outcome","volume":"117","author":"Landon","year":"2011","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.ecl.2013.07.007_bib157","first-page":"104","article-title":"Growth and neurodevelopmental outcome of children born to mothers with pregestational and gestational diabetes","volume":"3","author":"Ornoy","year":"2005","journal-title":"Pediatr Endocrinol Rev"},{"issue":"2","key":"10.1016\/j.ecl.2013.07.007_bib158","doi-asserted-by":"crossref","first-page":"340","DOI":"10.2337\/dc07-1596","article-title":"High prevalence of type 2 diabetes and prediabetes in adult offspring of women with gestational diabetes mellitus or type 1 diabetes: the role of intrauterine hyperglycemia","volume":"31","author":"Clausen","year":"2008","journal-title":"Diabetes Care"},{"issue":"Suppl 2","key":"10.1016\/j.ecl.2013.07.007_bib159","doi-asserted-by":"crossref","first-page":"S169","DOI":"10.2337\/dc07-s211","article-title":"The predisposition to obesity and diabetes in offspring of diabetic mothers","volume":"30","author":"Dabelea","year":"2007","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.ecl.2013.07.007_bib160","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1056\/NEJMoa042973","article-title":"Australian Carbohydrate Intolerance Study in Pregnant Women (ACHOIS) Trial Group. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes","volume":"352","author":"Crowther","year":"2005","journal-title":"N\u00a0Engl J Med"},{"issue":"14","key":"10.1016\/j.ecl.2013.07.007_bib161","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1056\/NEJMoa0902430","article-title":"A\u00a0multicenter, randomized trial of treatment for mild gestational diabetes","volume":"361","author":"Landon","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.ecl.2013.07.007_bib162","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0095-5108(18)30389-0","article-title":"Alternative therpaies for the management of gestational diabetes","volume":"20","author":"Mulford","year":"1993","journal-title":"Clin Perinatol"},{"issue":"6","key":"10.1016\/j.ecl.2013.07.007_bib163","doi-asserted-by":"crossref","first-page":"996","DOI":"10.2337\/dc09-0007","article-title":"Can a low-glycemic index diet reduce the need for insulin in gestational diabetes mellitus? A randomized trial","volume":"32","author":"Moses","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ecl.2013.07.007_bib164","series-title":"Weight gain during pregnancy: reexamining the recommendations","author":"Rasmussen","year":"2009"},{"issue":"1","key":"10.1016\/j.ecl.2013.07.007_bib165","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0029-7844(97)84256-1","article-title":"Effects of a partially home-based exercise program for women with gestational diabetes","volume":"89","author":"Avery","year":"1997","journal-title":"Obstet Gynecol"},{"issue":"Suppl 2","key":"10.1016\/j.ecl.2013.07.007_bib166","doi-asserted-by":"crossref","first-page":"s220","DOI":"10.2337\/dc07-s220","article-title":"Treatment with insulin and its analogs in pregnancies complicated by diabetes","volume":"30","author":"Jovanovic","year":"2007","journal-title":"Diabetes Care"},{"issue":"9","key":"10.1016\/j.ecl.2013.07.007_bib167","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.2337\/diacare.22.9.1422","article-title":"The metabolic and immunologic effects of insulin lispro in gestational diabetes","volume":"22","author":"Jovanovic","year":"1999","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.ecl.2013.07.007_bib168","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1093\/qjmed\/94.5.255","article-title":"Insulin lispro and regular insulin in pregnancy","volume":"94","author":"Bhattacharyya","year":"2001","journal-title":"QJM"},{"issue":"6","key":"10.1016\/j.ecl.2013.07.007_bib169","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/j.1464-5491.2004.01498.x","article-title":"Congenital anomaly rate in offspring of mothers with diabetes treated with insulin lispro during pregnancy","volume":"22","author":"Wyatt","year":"2005","journal-title":"Diabet Med"},{"issue":"1","key":"10.1016\/j.ecl.2013.07.007_bib170","doi-asserted-by":"crossref","first-page":"183","DOI":"10.2337\/diacare.26.1.183","article-title":"Comparison of an insulin analog, insulin aspart, and regular human insulin with no insulin in gestational diabetes mellitus","volume":"26","author":"Pettitt","year":"2003","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.ecl.2013.07.007_bib171","doi-asserted-by":"crossref","first-page":"186.e1","DOI":"10.1016\/j.ajog.2007.08.005","article-title":"Fetal and perinatal outcomes in type 1 diabetes pregnancy: a randomized study comparing insulin aspart with human insulin in 322 subjects","volume":"198","author":"Hod","year":"2008","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.ecl.2013.07.007_bib172","doi-asserted-by":"crossref","first-page":"771","DOI":"10.2337\/dc06-1887","article-title":"Maternal glycemic control and hypoglycemia in type 1 diabetic pregnancy: a randomized trial of insulin aspart versus human insulin in 322 pregnant women","volume":"30","author":"Mathiesen","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ecl.2013.07.007_bib173","doi-asserted-by":"crossref","first-page":"649070","DOI":"10.1155\/2012\/649070","article-title":"Meta-analysis of maternal and neonatal outcomes associated with the use of insulin glargine versus NPH insulin during pregnancy","volume":"2012","author":"Lepercq","year":"2012","journal-title":"Obstet Gynecol Int"},{"issue":"10","key":"10.1016\/j.ecl.2013.07.007_bib174","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.2337\/dc11-2264","article-title":"Maternal efficacy and safety outcomes in a randomized controlled trial comparing insulin detemir with NPH insulin in 310 pregnant women with type 1 diabetes mellitus","volume":"35","author":"Mathiesen","year":"2012","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.ecl.2013.07.007_bib175","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.ajog.2007.03.062","article-title":"Continuous subcutaneous insulin infusion vs. intensive conventional insulin therapy in pregnant diabetic women: a systematic review and metaanalysis of randomized, controlled trials","volume":"197","author":"Mukhopadhyay","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ecl.2013.07.007_bib176","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1136\/bmj.301.6760.1070","article-title":"Can prepregnancy care of diabetic women reduce the risk of abnormal babies?","volume":"301","author":"Steel","year":"1990","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.ecl.2013.07.007_bib177","first-page":"253","article-title":"Insulin requirements during pregnancy in women with type I diabetes","volume":"83","author":"Steel","year":"1994","journal-title":"Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.ecl.2013.07.007_bib178","doi-asserted-by":"crossref","first-page":"457.e1","DOI":"10.1016\/j.ajog.2010.06.044","article-title":"Oral hypoglycemic agents vs insulin in management of gestational diabetes: a systematic review and metaanalysis","volume":"203","author":"Dhulkotia","year":"2010","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.ecl.2013.07.007_bib179","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/AOG.0b013e318190a459","article-title":"Benefits and risks of oral diabetic agents compared with insulin in women with gestational diabetes: a systematic review","volume":"113","author":"Nicholson","year":"2009","journal-title":"Obstet Gynecol"},{"issue":"16","key":"10.1016\/j.ecl.2013.07.007_bib180","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1056\/NEJM200010193431601","article-title":"A\u00a0comparison of glyburide and insulin in women with gestaional diabetes mellitus","volume":"343","author":"Langer","year":"2000","journal-title":"N\u00a0Engl J Med"},{"issue":"19","key":"10.1016\/j.ecl.2013.07.007_bib181","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1056\/NEJMoa0707193","article-title":"Metformin versus insulin for the treatment of gestational diabetes","volume":"358","author":"Rowan","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.ecl.2013.07.007_bib182","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/AOG.0b013e3181c52132","article-title":"Metformin compared with glyburide in gestational diabetes: a randomized controlled trial","volume":"115","author":"Moore","year":"2010","journal-title":"Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.ecl.2013.07.007_bib183","doi-asserted-by":"crossref","first-page":"467.e1","DOI":"10.1016\/j.ajog.2010.05.032","article-title":"Gestational diabetes: risk of recurrence in subsequent pregnancies","volume":"203","author":"Getahun","year":"2010","journal-title":"Am J Obstet Gynecol"},{"issue":"9677","key":"10.1016\/j.ecl.2013.07.007_bib184","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/S0140-6736(09)60731-5","article-title":"Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis","volume":"373","author":"Bellamy","year":"2009","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.ecl.2013.07.007_bib185","first-page":"2342","article-title":"Predictive value of human leukocyte antigen class II typing for the development of islet autoantibodies and insulin-dependent diabetes postpartum in women with gestational diabetes","volume":"84","author":"Ferber","year":"1999","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.ecl.2013.07.007_bib186","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/(SICI)1099-0895(199612)12:4<275::AID-DMR170>3.0.CO;2-W","article-title":"Islet cell autoimmunity in women with\u00a0gestational diabetes and risk of progression to insulin-dependent diabetes mellitus","volume":"12","author":"Mauricio","year":"1996","journal-title":"Diabetes Metab Rev"}],"container-title":["Endocrinology and Metabolism Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852913000662?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852913000662?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:38:18Z","timestamp":1760175498000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889852913000662"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":186,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S0889852913000662"],"URL":"https:\/\/doi.org\/10.1016\/j.ecl.2013.07.007","relation":{},"ISSN":["0889-8529"],"issn-type":[{"value":"0889-8529","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diabetes and the Female Reproductive System","name":"articletitle","label":"Article Title"},{"value":"Endocrinology and Metabolism Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ecl.2013.07.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}